Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Abbott Laboratories (ABT)

Abbott Laboratories (ABT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Abbott Laboratories 100 ABBOTT PARK ROAD ABBOTT PARK IL 60064 USA

www.abbott.com Employees: 114,000 P: 224-667-6100

Sector:

Medical

Description:

Abbott Labs discovers, develops, manufactures & sells a diversified line of health care products. Established Pharmaceuticals Division includes branded generics business in the emerging markets. Medical Devices unit includes the diabetes care, vision care & vascular businesses. Diagnostics unit manufactures and markets diagnostic systems and tests in four business lines core laboratory, molecular, point of care and rapid diagnostics. Nutrition unit includes a broad line of pediatric and adult nutritional products. Abbott acquired CFR Pharmaceuticals, Tendyne Holdings, Inc., St. Jude Medical and Alere Inc. On the other hand, Abbott sold its developed markets branded generics pharmaceuticals business to Mylan. Abbott retained the branded generics pharmaceuticals business in emerging markets. Abbott sold its animal health business to Zoetis Inc and divested its vision care business, Medical Optics, to Johnson & Johnson.

Key Statistics

Overview:

Market Capitalization, $K 189,571,824
Enterprise Value, $K 196,080,832
Shares Outstanding, K 1,738,872
Float, K 1,730,873
% Float 99.54%
Short Interest, K 19,915
Short Float 1.15%
Days to Cover 3.31
Short Volume Ratio 0.24
% of Insider Shareholders 0.46%
% of Institutional Shareholders 75.18%

Financials:

Annual Sales, $ 44,328 M
Annual Net Income, $ 6,524 M
Last Quarter Sales, $ 11,459 M
Last Quarter Net Income, $ 1,776 M
EBIT, $ 9,735 M
EBITDA, $ 12,953 M

Growth:

1-Year Return -15.25%
3-Year Return 0.80%
5-Year Return -14.98%
5-Year Revenue Growth 28.09%
5-Year Earnings Growth 41.10%
5-Year Dividend Growth 63.89%

Per-Share Information:

Most Recent Earnings 1.50 on 01/22/26
Next Earnings Date 04/15/26
Earnings Per Share ttm 5.15
EPS Growth vs. Prev Qtr 15.38%
EPS Growth vs. Prev Year 11.94%
Annual Dividend & Yield (Paid) 2.40 (2.20%)
Annual Dividend & Yield (Fwd) 2.52 (2.30%)
Most Recent Dividend 0.630 on 01/15/26
Next Ex-Dividends Date 01/15/26
Dividend Payable Date 02/13/26
Dividend Payout Ratio 45.41%
Most Recent Split 2-1 on 01/02/13

ABT Ratios

Ratio
Price/Earnings ttm 21.24
Price/Earnings forward 19.27
Price/Earnings to Growth 1.74
Return-on-Equity % 17.94%
Return-on-Assets % 10.86%
Profit Margin % 14.72%
Debt/Equity 0.25
Price/Sales 4.29
Price/Cash Flow 17.74
Price/Book 3.71
Book Value/Share 29.48
Interest Coverage 46.76
60-Month Beta 0.75

ABT Dividends

Date Value
01/15/26 $0.6300
10/15/25 $0.5900
07/15/25 $0.5900
04/15/25 $0.5900
01/15/25 $0.5900
10/15/24 $0.5500
07/15/24 $0.5500
04/12/24 $0.5500
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar